IL6 and COVID-19: However, currently identified blood biomarkers such as interleukin-6 (IL-6), lactate dehydrogenase or procalcitonin, analyzed as standard of care on admission to hospital, have only moderate predictive value for mortality for COVID-19 compared to age or comorbidities [6,7].